Monthly Archives: August 2023

//August

Government u-turn on Covid-19 and flu vaccines means ‘time is now incredibly tight’ for pharmacy teams

Daily Mail  In response to the BA.2.86 variant and UKHSA guidance, DHSC have brought the start of the Autumn Covid-19 and flu vaccinations programme forward to 11th September 2023, to expedite vaccinations for eligible individuals. The Daily Mail explored how this change in plans will impact pharmacy teams and their delivery of Covid-19 and flu [...]

The post Government u-turn on Covid-19 and flu vaccines means ‘time is now incredibly tight’ for pharmacy teams appeared first on Community Pharmacy England.

By |August 31st, 2023|Lexpos News|Comments Off on Government u-turn on Covid-19 and flu vaccines means ‘time is now incredibly tight’ for pharmacy teams

MHRA Drug Safety Update August 2023

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 1 August 2023) has been published and includes articles on: Fluoroquinolone antibiotics: reminder of the risk of disabling and potentially long-lasting or irreversible side effects Methotrexate: advise patients to take precautions in the sun to avoid photosensitivity reactions Valproate: re-analysis [...]

The post MHRA Drug Safety Update August 2023 appeared first on Community Pharmacy England.

By |August 31st, 2023|Lexpos News|Comments Off on MHRA Drug Safety Update August 2023

MHRA Class 4 Medicines Defect Information: Tostran (Testosterone 2% gel) (Kyowa Kirin Limited)

Class 4 Medicines Defect Information:Tostran (Testosterone 2% gel) (Kyowa Kirin Limited) Drug alert number: EL (23)A/33 Date issued: 31 August 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Tostran (Testosterone 2% gel), Kyowa Kirin Limited Company name: Galderma (U.K.) Limited Product name: LTostran (Testosterone [...]

The post MHRA Class 4 Medicines Defect Information: Tostran (Testosterone 2% gel) (Kyowa Kirin Limited) appeared first on Community Pharmacy England.

By |August 31st, 2023|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Tostran (Testosterone 2% gel) (Kyowa Kirin Limited)

Atomoxetine 18mg capsules – updated reimbursement price for August 2023

During the month of August 2023, Community Pharmacy England received several reports from pharmacy owners unable to obtain Atomoxetine 18mg capsules (28) at the published Drug Tariff price of £14.72. A price concession of £26.35 was granted by the Department of Health and Social Care (DHSC) and this was communicated in the final August price [...]

The post Atomoxetine 18mg capsules – updated reimbursement price for August 2023 appeared first on Community Pharmacy England.

By |August 31st, 2023|Lexpos News|Comments Off on Atomoxetine 18mg capsules – updated reimbursement price for August 2023

New educational supervisor training offer for community pharmacy professionals

NHS England are offering 1,000 fully funded module places to support educational supervisor training for community pharmacists and pharmacy technicians. The training will be delivered by ProPharmace from September 2023. The offer provides 500 places for Designated Prescribing Practitioners (DPP) and 500 places for other educational supervisors, including Designated Supervisors (DSs). The training is designed [...]

The post New educational supervisor training offer for community pharmacy professionals appeared first on Community Pharmacy England.

By |August 30th, 2023|Lexpos News|Comments Off on New educational supervisor training offer for community pharmacy professionals